BioSpace News Archive

Pharm Country

Pfizer Q3: 2021 Guidance Raised to $81 Billion+, Strong Vaccine Sales and Gene Therapy Delays

Pfizer reported its third-quarter 2021 financials, citing $24.1 billion in quarterly revenues, a stunning 130% operational growth.

November 2, 2021
·
3 min read
·
Mark Terry
Business

BioNet and Sartorius’ Company BIA Separations Collaborate on Production Process Development of mRNA Vaccines

BioNet, a leading biotech company manufacturing genetically engineered vaccines, and BIA Separations, now part of Sartorius, a leading biochromatography development and manufacturing company, announced the successful development of an optimized mRNA manufacturing process.

November 2, 2021
·
2 min read
Business

Galecto Announces Clinical Collaboration with Roche for Phase 2 Trial of GB1211 in Combination with Atezolizumab in First Line Non-Small-Cell Lung Cancer

Galecto, Inc. today announced that it has entered into a clinical trial supply agreement with Roche to explore the combination of GB1211 with Roche’s PD-L1 checkpoint inhibitor atezolizumab (Tecentriq®) in Galecto’s planned Phase 2a trial in non-small-cell lung cancer (NSCLC).

November 2, 2021
·
5 min read
Pharm Country

Intercept Announces Late-Breaking Oral Presentation and Poster Presentations at The Liver Meeting

Intercept Pharmaceuticals, Inc. today announced that multiple abstracts on obeticholic acid (OCA) will be presented at The Liver Meeting 2021, the annual meeting of the American Association for the Study of Liver Diseases (AASLD).

November 2, 2021
·
19 min read
Drug Development

Metacrine Reports Topline Results for MET409 Phase 2a Combination Trial In Patients with Type 2 Diabetes and NASH

Metacrine, Inc. today reported topline results from its Phase 2a trial evaluating MET409

November 2, 2021
·
5 min read
Business

Evolus Reports Third Quarter 2021 Results and Provides Business Update

Evolus, Inc. today reported financial results for the third quarter ended September 30, 2021.

November 2, 2021
·
15 min read
BioCapital

Acumen Pharmaceuticals to Present Clinical Trial Design for INTERCEPT-AD, the Phase 1 Placebo-Controlled, Single- and Multiple-Dose Clinical Trial of ACU193, at 2021 Clinical Trials on Alzheimer’s Disease (CTAD) Conference

Acumen announced dosing of first patient in INTERCEPT-AD in October 2021 and enrollment of patients with early Alzheimer’s disease is ongoing

November 2, 2021
·
5 min read
Biotech Beach

Shoreline Biosciences Announces $140M Financing To Advance Pipeline Of Next Generation Cell Immunotherapies

Shoreline Biosciences, Inc. today announced the completion of a $140M financing, led by Ally Bridge Group, with participation from new investors Eventide Asset Management, BeiGene, Irving Investors, Kingdon, NS Investment, Piper Heartland Healthcare Capital, and Superstring.

November 2, 2021
·
3 min read
Business

Nautilus and Abcam Announce Strategic Partnership to Accelerate Exploration of the Proteome

Nautilus Biotechnology, Inc., a company pioneering a single-molecule protein analysis platform for quantifying the proteome, and Abcam, a global innovator in life sciences research tools, announced a strategic development and supply partnership.

November 2, 2021
·
7 min read
Pharm Country

Seelos Therapeutics to Participate in Two Investor Conferences

Seelos Therapeutics, Inc. today announced that it will participate in the Guggenheim Healthcare Talks, Idea Forum, 3rd Annual Neuro/Immunology Day on November 15-16th

November 2, 2021
·
2 min read